Search results - ORA - Oxford University Research Archive

« Previous | 1 - 10 of 34 | Next »

1

Journal article

The immune landscape in BCR-ABL negative myeloproliferative neoplasms: inflammation, infections and opportunities for immunotherapy

Strickland, M, Quek, L, Psaila, B
2021-10-07

2

Conference item

Repressed chromatin drives leukaemogenesis in mutant IDH2 acute myeloid leukaemia via inhibition of granulocyte differentiation and cell cycle progression

Silveira, DRA, Chatzikyriakou, P, Yavorska, O, et al.
2021-11-23

3

Journal article

A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings?

Silveira, DRA, Coelho-Silva, JL, Silva, WF, et al.
2020-09-30

4

Journal article

Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation

Crump, NT, Hadjinicolaou, AV, Xia, M, et al.
2021-05-11

5

Journal article

Integrating clinical features with genetic factors enhances survival prediction for adults with acute myeloid leukemia

Silveira, DRA, Quek, L, Santos, IS, et al.
2020-05-26

6

Conference item

Therapy-Related Myeloid Neoplasms with Balanced Chromosome Rearrangements Frequently Arise from Pre-Existing Clonal Haematopoiesis

Dillon, R, Jovanovic, J, Potter, N, et al.
2018-11-21

7

Conference item

NGS IDENTIFIES MUTATIONS PROGNOSTIC OF RELAPSE AFTER ALLO-SCT AND NOVEL CLONE EMERGENCE AT DISEASE RECURRENCE: IMPLICATIONS FOR STRATEGIES TO PREVENT POST ALLO-SCT RELAPSE

Quek, L, Ferguson, P, Metzner, M, et al.
2016-06-06

8

Conference item

Analysis of arginine metabolism in acute myeloid leukaemia to provide insights into tumour immune escape strategies

Hadjinicolaou, A, Prota, G, Scifo, L, et al.
2017-02-23

9

Conference item

Vorinostat does not improve outcome in patients with acute myeloid leukemia and high risk myelodysplasia treated with azacitidine: Results of the UK Trials Acceleration Programme Ravva Trial

Craddock, C, Houlton, A, Ferguson, P, et al.
2016-12-01

10

Journal article

TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups

Haase, D, Stevenson, KE, Neuberg, D, et al.
2019-01-11

TO TOP